Wu Yifang
| Company | Stock Code | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|---|
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 02196 | 01-Jun-22 | Ch | |||
| SISRAM MEDICAL LTD | 01696 | 17-Oct-16 | NED | |||
| Shanghai Henlius Biotech, Inc. | 02696 | 12-Jun-15 | NED | |||
| FOSUN PHARMA | 02196 | 07-Jun-16 | 30-Sep-25 | NED | Resigned due to personal work reassignment. | |
| FOSUN PHARMA | 02196 | 07-Jun-16 | 29-Apr-25 | ED | Resigned due to adjustment of work arrangements. Wu has been re-designated from an executive Director to a non-executive Director | |
| FOSUN PHARMA | 02196 | 29-Oct-20 | 01-Jun-22 | CEO | Due to the adjustment of work arrangement | |
| SINOPHARM GROUP CO. LTD. | 01099 | 18-Sep-20 | 10-Jun-21 | Ch, Ind Sup | ||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 02196 | 31-Aug-16 | 29-Oct-20 | Pres | ||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 02196 | 07-Jun-16 | 31-Aug-16 | Non-dir |